fbpx Skip to main content

Archived Events

September 15 | COVID19 – the Good, the Bad and the Ugly
We are now 6 months into the pandemic. What have we learned, what do we still need to know and where are we going in both our business and personal lives? Last week, Biocom’s Medical Device & Diagnostics Committee answered these question’s in their webinar titled COVID-19: The Good, the Bad and the Ugly.

View Webinar 

 

September 2 | Return to Work: Paid Leave
The pandemic has changed our day-to-day operations and employers are working with employees who may be struggling with the balance. COVID-19 has created novel issues that impact our employees’ ability to work or to enter the workplace, ranging from childcare issues, living with at-risk individuals, being at-risk personally, to contracting COVID-19. As increasing time off and other accommodation requests flood in, how do new and existing laws shape what accommodations you may or must provide to your employees?

VIEW WEBINAR

 

September 1 | Logistics Requirements for Cell Based Therapies
Learn how Gilead Sciences is adapting warehousing and supply chain operations to meet the needs of cell therapies including long-term cell banking operations and raw material inventory management. Kevin Hickman will describe how to assess all supply chain touchpoints (manufacturing, packaging and distribution) and their temperature management capabilities.

VIEW WEBINAR

 

August 25 | Return to Work: Preparing For a Changing Workforce Landscape
Our panel discusses “Strategic Workforce Planning” and how life science companies will need to adapt and adopt new recruitment and retention strategies in order to stay competitive in the marketplace.

VIEW WEBINAR

 

August 21 | Biocom Briefings Webinar Series, Part I
This is the first in a series of webinars on COVID-19 and the life science industry. This session gives a broad view of industry efforts in fighting COVID-19, and the unprecedented collaborations happening with academia, research institutions and commercial companies. Future sessions will focus specifically within individual topic areas, such as testing, vaccines, therapeutics, and plasma-based therapies.

VIEW WEBINAR

 

August 5 | Critical Look: Finally, Value-Based Insights Fitting into the Biotech Culture
Biotech companies need to demonstrate the value of their asset(s) in order to optimize their partnerships or have a successful public offering. The market insights required to drive that valuation include a deep understanding of the market landscape, key unmet needs and how other molecules may fulfill those, and what a successful clinical trial design should look like. Shaping your target product profile in light of the external environment is a critical success factor for maximizing the value of your asset and/or company.

VIEW WEBINAR

 

August 4 | GxP 101: Creating a Workable User Requirement Specification (URS) for your Life Science Facility
New and growing life science facilities need to understand GMP/GDP requirements that are imperative to regulatory compliance and smooth running operations. Walk though setting up an effective URS that will help you identify a Validation Master Plan and DQ/IQ/OQ/PQ needs, using examples of manufacturing and logistics facilities.

VIEW WEBINAR

 

July 28 | Back to the Lab: Cell Culture Incubator Best Practices and Design Comparisons
In spring 2020, many laboratories were shut down, nevertheless the science did not stop. Join us as we learn some best practices to restart and maintain your CO2 incubator. A good CO2 incubator design should not only provide ideal conditions for cell health, but also help to limit process variables that can jeopardize downstream results. These considerations are especially critical with sensitive cells including primary cells, stem cells and immune cells as well as for viral studies and propagation. We will present comparison data from different incubator models to demonstrate performance differences.

VIEW WEBINAR

 

July 21 | CFO Webinar Series: Current Life Science Venture Capital Investment Landscape
Hear from three top Venture Capital leaders in the Life Science industry. Our VC panel will share how they are approaching a changed investment landscape, discussing COVID-19’s impact on new market opportunities, the way deals are being executed, the effects on secondary markets, M&A, corporate partnerships, and more.

VIEW WEBINAR

 

July 15 | Biocom/Illumina Webinar on the Use of Genomics in Response to the COVID-19 Pandemic
Hear from both government and industry about the role genomics in combating the disease, their joint efforts to track, contain, and treat the spread to prevent or mitigate future pandemics.

VIEW WEBINAR

 

July 14 | NCI SBIR & STTR: Advancing the Commercialization of New Cancer Innovations
The SBIR/STTR Development Center provides funding, mentoring and networking assistance to small businesses that demonstrate promising next-generation cancer cure technologies. During this webinar, presenter Christie Canaria, Ph.D., Program Director at the National Cancer Institute SBIR Development Center went over SBIR/STTR eligibility requirements and shared strategies on how to successfully submit competitive research proposals.

VIEW WEBINAR Event Materials

 

June 30 | Return to Work Series: Testing: What You as Employers Need to Know
View our second installment of the Return to Work Webinar Series focused on Testing. Topics covered by our expert panel include what employers should know about PCR testing vs. Serology testing, symptomatic vs. asymptomatic testing, financing testing, incident management and much more.

View Webinar

 

June 23 | Biocom Workshop: Adapting Your Facility to COVID-19 Measures
Learn best practices on adjusting your workplace spacing, logging, and flow to decrease the possibility of transferring COVID-19.

LEARN MORE

 

June 17 | Return to Work Series: COVID-19 Testing Foundations That We All Need to Know
As you are preparing to return to a physical office space, testing is top of mind for everyone. During this webinar our experts provide a foundational overview of the different testing options available including Molecular, Antigen, and Antibody.

View Webinar

 

June 16 | Current Trends in Venture Funding: Perspective on Investments Post-Pandemic
Everyone in the life sciences industry has had to deal with a new reality after the pandemic hit. Clinical trial plans have been postponed, moving from in-person to virtual, adapting to a new normal. But through it all, life sciences experts are getting things done. We’ll talk to a panel involving some experienced VCs as they discuss managing investment opportunities in a new and different world.

View Webinar

 

May 13 | Return to Workplace – Insights from Life Science CEOs Across the US
Join Biocom, MassBio and Thermo Fisher Scientific as we convene industry CEOs to share their insights on COVID-19 testing, the race for a vaccine, as well as how these leaders are preparing for the return of
their workforce. In this ever changing landscape guidance’s and best practices are changing every day. CEO’s from East and West provide you with the most updated information.

View Webinar

 

May 13 | CFO Series Webinar: Discussion with Chief Economist of Nasdaq
View this webinar to hear from Chief Economist and Senior
Vice President of Nasdaq, Inc., Phil Mackintosh.

View Webinar
Password: BiocomCFO2020

 

May 8 | Live Webinar Discussion: Payment Protection Program (PPP) and Economic Injury Disaster Loans (EIDL)
Please join Biocom and the Small Business Administration (SBA) for a discussion about the Payment
Protection Program (PPP) and Economic Injury Disaster Loans (EIDL) programs. You’ll learn about the
loan and grant programs, application process, tips, and what to expect after applying, among others.

View Webinar

 

May 5 | Working Through FDA’s Emergency Use Authorization (EUA) Pathway in the Era of COVID-19
This one-hour webinar is designed for companies and entrepreneurs looking to launch new Personal Protective Equipment (PPE), Diagnostic Tests and Other Medical Devices to combat the COVID-19 Pandemic.

View Webinar